Wednesday, August 5, 2026
Important update regarding the reimbursement of ruxolitinib cream (brand name Opzelura)
On June 15, the final meeting took place between Zorginstituut Nederland, Vitiligo.nl, Huid Nederland, and the Dutch Society for Dermatology and Venereology (NVDV). On behalf of everyone with vitiligo, we have once again made it clear that vitiligo is much more than a skin condition.